Companies that own Nanobiotix
JPMorgan Asset Management (UK) Ltd.
880,920
4.49%
-13,914
0.02%
09/12/2017
AXA Investment Managers UK Ltd.
307,677
1.57%
307,677
0.02%
02/28/2018
Norges Bank Investment Management
207,173
1.06%
-1
0%
12/31/2017
APG Asset Management NV
157,853
0.8%
-18,203
0%
03/31/2018
Aviva Investors France SA
145,886
0.74%
0
0.05%
08/31/2018
HSBC Global Asset Management (France) SA
126,392
0.64%
-2,488
0.04%
12/29/2017
AXA Investment Managers (Paris) SA
114,000
0.57%
114,000
0.02%
12/31/2017
Keren Finance SAS
100,000
0.51%
100,000
0.91%
06/30/2017
Ostrum Asset Management
80,000
0.41%
0
0%
06/29/2018
Amilton Asset Management SA
61,947
0.32%
61,947
0.56%
06/30/2017
| Address |
60, rue de Wattignies
Paris Ile-de-France 75012
France
|
|
Employees
|
- |
| Website |
http://www.nanobiotix.com |
| Updated |
07/08/2019 |
| Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company's technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. It also engages in the development of magnetic particles and laser activated nanoparticles for the treatment and diagnosis of cancer. |
